Interactions between MDSCs and the Autonomic Nervous System: Opportunities and Challenges in Cancer Neuroscience

Cancer Immunol Res. 2024 Jun 4;12(6):652-662. doi: 10.1158/2326-6066.CIR-23-0976.

Abstract

Myeloid-derived suppressor cells (MDSC) are a population of heterogeneous immune cells that are involved in precancerous conditions and neoplasms. The autonomic nervous system (ANS), which is composed of the sympathetic nervous system and the parasympathetic nervous system, is an important component of the tumor microenvironment that responds to changes in the internal and external environment mainly through adrenergic and cholinergic signaling. An abnormal increase of autonomic nerve density has been associated with cancer progression. As we discuss in this review, growing evidence indicates that sympathetic and parasympathetic signals directly affect the expansion, mobilization, and redistribution of MDSCs. Dysregulated autonomic signaling recruits MDSCs to form an immunosuppressive microenvironment in chronically inflamed tissues, resulting in abnormal proliferation and differentiation of adult stem cells. The two components of the ANS may also be responsible for the seemingly contradictory behaviors of MDSCs. Elucidating the underlying mechanisms has the potential to provide more insights into the complex roles of MDSCs in tumor development and lay the foundation for the development of novel MDSC-targeted anticancer strategies.

Publication types

  • Review

MeSH terms

  • Animals
  • Autonomic Nervous System* / physiopathology
  • Humans
  • Myeloid-Derived Suppressor Cells* / immunology
  • Neoplasms* / immunology
  • Signal Transduction
  • Tumor Microenvironment*